ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)
$5.19 -0.06 (-1.1429%)
Analysed ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) News Sources
Jazz Pharmaceuticals (JAZZ) Expands AbCellera Tie Up As Zepzelca Trial Misses Goal
24-06-2026
yahoo.com
Enanta Pharmaceuticals (ENTA) Moves 5.2% Higher: Will This Strength Last?
24-06-2026
yahoo.com
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?
25-06-2026
yahoo.com
Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week?
29-06-2026
stocktwits.com
Is AbCellera Biologics (ABCL) One of the Best Stocks with Biggest Upside?
01-07-2026
yahoo.com
Is ABCELLERA BIOLG (ABCL) Stock Outpacing Its Medical Peers This Year?
03-07-2026
yahoo.com
AbCellera Appoints Dr. Lynn Seely to its Board of Directors
06-07-2026
yahoo.com
Are You Looking for a Top Momentum Pick? Why AbCellera Biologics Inc. (ABCL) is a Great Choice
07-07-2026
yahoo.com
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
07-07-2026
yahoo.com
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
15-07-2026
yahoo.com
What is the current price of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The current price of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is $5.19.
ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) absolute price change since previous trading day?
The absolute price change of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) since the previous trading day is $-0.06.
ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) percentage price change since previous trading day?
The percentage price change of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) since the previous trading day is -1.1429%.
What is the most recent average sentiment score for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The most recent average sentiment score for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The most recent sentiment for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is .
SEC-8K** Filing Available For ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.